Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA between February 13 th and 15 th 2025, was host to the Case-Based Session: Management of ...

The connection between obesity and thyroid cancer underscores the importance of maintaining a healthy weight. With scientific ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

In Meraouna et al.'s study, the failure-free survival rate was 66% at 3 years of follow-up. Regarding treatment-related morbidities, 12.3% of patients experienced grade 3 genitourinary (GU) toxicity, ...

In some cases, doctors may use the test to diagnose thyroid cancer, or other damage to the ... but they carry a small risk of complications. A person may feel slight pain or discomfort when ...

Cancer patients with high muscle strength and cardiorespiratory fitness levels have significantly lower risk for all-cause mortality. HealthDay News — For patients diagnosed with cancer, high muscle ...

Exposure to high-normal, compared with low-normal, TSH levels was not associated with an elevated risk for differentiated thyroid cancer recurrence after thyroidectomy. Exposure to high-normal ...

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

Aspirin reduced the risk of colorectal cancer recurrence by more than 50% in patients with PI3K-mutated disease who took a low dose once a day for 3 years, according to newly released data from the ...

“Aspirin has been shown to effectively reduce recurrence rates and improve disease-free survival,” said Anna Martling, MD, PhD. In patients with PIK3CA alterations in exon 9 and/or 20, the ...